BETA: Please send your feedback!
Neuralstem
CUR:NAS
Biotechnology
$0
MICRO cap
$1.52
(0.00%)
-0.77%
since start of 2020
-0.20
- —
- 1
- 2
- 3
- 4
- 5
About
Biotechnology
Founded 1996
Neuralstem, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of central nervous system therapies based on human neuronal stem cells and small molecule compounds. Its pipeline includes NSI-189 small molecule program, NSI-566 stem cell therapy program, and novel and proprietary chemical entity screening platform. The company was founded by I. Richard Garr, Karl Y. Johe, and Merrill Solomon in 1996 and is headquartered in Germantown, MD.
website
Headquarters
Executives
| Name | Title | Gender |
| I. Richard Garr | Founder | Male |
| Karl Y. Johe, PhD | Chief Scientific Officer | Male |
| Merrill Solomon | Founder | Male |
| Danielle Spangler | Investor Relations Contact | Female |
| Richard J. Daly, MBA | Chairman, President, Chief Executive Officer & CFO | Male |
Mindful Investing Summary
- —
- 1
- 2
- 3
- 4
- 5
Neuralstem - Competitors and Related Companies
How Neuralstem stacks up to its peers in the Biotechnology industry or with competing business segments.
Neuralstem
CUR:NAS
Biotechnology
$0
MICRO cap
$1.52
(0.00%)
-0.77%
since start of 2020
-0.20
Loading…